S&P 500
7,549.40
-0.01%
Dow Jones
52,651.70
+0.26%
Nasdaq 100
29,667.40
-0.28%
Russell 2000
2,997.51
+0.23%
FTSE 100
10,506.00
+0.25%
Nikkei 225
68,854.70
-0.25%

Retail

Walgreen Sales Dive in September

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Invalid Image
Same-store sales at Walgreen Co. (NYSE: WAG) dropped 7.8% in September, compared with sales in September 2011, from $5.94 billion to $5.48 billion. Customer traffic fell 2.3% while the average sales ticket rose by 0.8%.

The biggest problem was prescription sales, down 10.3% at comparable stores. Total pharmacy sales were down 12.3% year-over-year for the month, while same-store pharmacy sales fell 16.1%. Pharmacy sales accounted for 63.7% of September sales.

Walgreen’s contract dispute with Express Scripts Holding Co. (NASDAQ: ESRX) was not resolved in time to have a positive impact on September sales. Now the question becomes whether Walgreen can win back those customers it lost during the period when it had no contract with the country’s largest pharmacy benefits manager. Walgreen said it lost $0.06 per share in earnings during its most recent fiscal quarter due to the loss of its Express Scripts contract.

Shares are trading down 1.7% at $36.30 in a 52-week range of $28.53 to $37.35, a new high posted yesterday.

Paul Ausick

Contact [email protected] for any questions or corrections.

DISCLOSURE:
INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA(www.finra.org)/SIPC(www.sipc.org). Advisory services are offered by SoFi Wealth LLC, an SEC-registered investment adviser. Information about SoFi Wealth’s advisory operations, services, and fees is set forth in SoFi Wealth’s current Form ADV Part 2 (Brochure), a copy of which is available upon request and at www.adviserinfo.sec.gov. Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 30 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. Investing in alternative investments and/or strategies may not be suitable for all investors and involves unique risks, including the risk of loss. An investor should consider their individual circumstances and any investment information, such as a prospectus, prior to investing. Interval Funds are illiquid instruments, the ability to trade on your timeline may be restricted. Brokerage and Active investing products offered through SoFi Securities LLC, Member FINRA(www.finra.org) /SIPC(www.sipc.org). There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event. Options involve risks, including substantial risk of loss and the possibility an investor may lose the entire investment Before trading options please review the Characteristics and Risks of Standardized Options  Investing in an Initial Public Offering (IPO) involves substantial risk, including the risk of loss. Further, there are a variety of risk factors to consider when investing in an IPO, including but not limited to, unproven management, significant debt, and lack of operating history. For a comprehensive discussion of these risks please refer to SoFi Securities’ IPO Risk Disclosure Statement This should not be considered a recommendation to participate in IPOs and investors should carefully read the offering prospectus to determine whether an offering is consistent with their investment objectives, risk tolerance, and financial situation. New offerings generally have high demand and there are a limited number of shares available for distribution to participants. Many customers may not be allocated shares and share allocations may be significantly smaller than the shares requested in the customer’s initial offer (Indication of Interest). For more information on the allocation process please visit IPO Allocation.
Follow 24/7 Wall St. on Google
Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Everyone's Chasing Florida. Smart Retirees Are Quietly Buying Here Instead.
Drew Wood |

Everyone's Chasing Florida. Smart Retirees Are Quietly Buying Here Instead.
Uncomfortable Math: A $2 Million Nest Egg at 66 Buys About $44,000 a Year
Carl Sullivan |

Uncomfortable Math: A $2 Million Nest Egg at 66 Buys About $44,000 a Year

Continue Reading

Paul Ausick |

Walgreen’s Same-Store Sales Dive

Drug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to…

Paul Ausick |

Walgreens Reports Drop in Same-store Sales (WAG, ESRX)

Pharmacy retailer Walgreens (NYSE: WAG) reported same-store sales for February were down -4.6% compared with February 2011. The number of…

Paul Ausick |

Walgreen Results Send Shares Sliding

courtesy of WalgreenWalgreen Co. (NYSE: WAG) reported first-quarter fiscal 2013 results before markets opened this morning. The drug store chain…

Jon C. Ogg |

Walgreen Sales Report Looks Poor on Most Fronts

ThinkstockWalgreen Co. (NYSE: WAG) is still trying to recover from weak comparable store sales figures. The drug store giant reported…

Paul Ausick |

Walgreen Margins Drop, Chop Profits

Walgreen reported disappointing second-quarter fiscal 2014 results before markets opened Tuesday morning, though prescription sales and front-end sales were higher.

Paul Ausick |

CVS Beats Estimates, Raises EPS Guidance

ThinkstockCVS Caremark Corp. (NYSE: CVS) reported third-quarter 2012 earnings this morning. The pharmacy benefits management and retail sales firm posted…

Paul Ausick |

Walgreen’s Misses Estimates, Promises Answer on Offshore Move

Walgreen reported third-quarter fiscal 2014 results before markets opened Tuesday morning and withdrew its fiscal 2016 goals in lieu of…

Trey Thoelcke |

CVS Falls Short of Estimates, Raises Outlook

This morning, CVS Caremark Corp. (NYSE: CVS) reported second-quarter earnings of $966 million, or $0.75 per share, and $30.7 billion…

Paul Ausick |

Walgreen Stages a Comeback

Walgreen Co. (NYSE: WAG) reported fiscal fourth-quarter 2012 earnings per share (EPS) of $0.63 on revenue of $17.07 billion. In…

Top Gaining Stocks

Hewlett Packard Enterprise
HPE • Vol: 26,431,700
Norwegian Cruise Line
NCLH • Vol: 17,600,839
Lam Research
LRCX • Vol: 12,118,424
Invesco
IVZ • Vol: 4,557,369
AMD
AMD • Vol: 26,902,257

Top Losing Stocks

Coterra Energy
CTRA • Vol: 73,319,495
APA
APA • Vol: 4,400,255
New Pluto Global
PSKY • Vol: 18,873,941
Costco
COST • Vol: 4,545,300
Cincinnati Financial
CINF • Vol: 2,196,176